MiMedx Group, Inc MDXG
4.67
(0.04)
(0.85%)
as of 25 Sep
- Market cap
- $686.5M
- P/E
- 117×
Follow MDXG
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
19.44% | 21.61% | 13.77% | 2.88% | |
| 14.51% | 16.02% | 10.60% | 2.18% | ||
ROIC |
29.26% | 36.84% | 24.56% | 5.62% | |
Return on Tangible Assets |
20.27% | 22.29% | 15.31% | 3.63% | |
Average Days of Receivables |
72.53 | 66.01 | 43.15 | 42.44 | |
Free Cash Flow per Share |
0.45 | 0.49 | 0.47 | 0.30 | |
Free Cash Flow |
66.81 | 72.97 | 69.31 | 44.43 | |
Capital Expenditures |
(1.02) | (1.03) | (1.27) | (1.72) | |
Piotroski F-Score |
5.00 | 5.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
16.99% | 16.79% | 16.79% | 12.50% | |
Accounts Receivable Turnover |
5.95 | 6.37 | 7.19 | 6.43 | |
Accounts Payable Turnover |
7.73 | 6.66 | 7.26 | 8.95 | |
Inventory Turnover |
2.79 | 2.97 | 2.94 | 3.28 | |
Average Days of Payables |
58.79 | 72.63 | 56.68 | 40.29 | |
Days of Inventory on Hand |
136.50 | 126.68 | 129.68 | 101.70 | |
Tax Rate |
(0.27) | (0.27) | (0.27) | (0.46) | |
Research and Development Expense of Revenue |
3.53% | 3.61% | 4.09% | 4.33% | |
Selling, General and Administrative Expense of Revenue |
64.60% | 63.59% | 66.63% | 71.82% | |
Share Based Compensation of Revenue |
4.73% | 3.92% | 2.68% | 1.86% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.66 | 1.52 | 2.30 | 7.40 | |
Depreciation/Fixed assets |
2.93 | 3.16 | 2.80 | 2.37 | |
Capex/Depreciation |
(0.07) | (0.07) | (0.10) | (0.15) | |
Revenue per Share |
2.66 | 2.83 | 2.62 | 2.40 | |
Operating CF per Share |
0.46 | 0.50 | 0.48 | 0.31 | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
10.38% | 11.60% | 7.88% | 1.76% |
Columns are period end dates